Thalidomide in Crohn's disease

被引：105

作者：

Wettstein, AR

Meagher, AP

机构：

[1] ST VINCENTS HOSP,DEPT GASTROENTEROL,SYDNEY,NSW 2010,AUSTRALIA

[2] ST VINCENTS HOSP,DEPT COLORECTAL SURG,SYDNEY,NSW 2010,AUSTRALIA

来源：

LANCET | 1997年 / 350卷 / 9089期

关键词：

D O I：

10.1016/S0140-6736(05)64206-7

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1445 / 1446

页数：2

共 5 条

[1] TUMOR-NECROSIS-FACTOR-ALPHA IN STOOL AS A MARKER OF INTESTINAL INFLAMMATION [J].

BRAEGGER, CP ;

NICHOLLS, S ;

MURCH, SH ;

STEPHENS, S ;

MACDONALD, TT .

LANCET, 1992, 339 (8785) :89-91

[2] Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection [J].

Jacobson, JM ;

Greenspan, JS ;

Spritzler, J ;

Ketter, N ;

Fahey, JL ;

Jackson, JB ;

Fox, L ;

Chernoff, M ;

Wu, AW ;

MacPhail, LA ;

Vasquez, GJ ;

Wohl, DA .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (21) :1487-1493

[3] Randomised controlled trial of CDP571 antibody to tumour necrosis factor-alpha in Crohn's disease [J].

Stack, WA ;

Mann, SD ;

Roy, AJ ;

Heath, P ;

Sopwith, M ;

Freeman, J ;

Holmes, G ;

Long, R ;

Forbes, A ;

Kamm, MA ;

Hawkey, CJ .

LANCET, 1997, 349 (9051) :521-524

[4] A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease [J].

Targan, SR ;

Hanauer, SB ;

vanDeventer, SJH ;

Mayer, L ;

Present, DH ;

Braakman, T ;

DeWoody, KL ;

Schaible, TF ;

Rutgeerts, PJ .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (15) :1029-1035

[5] THALIDOMIDE TREATMENT REDUCES TUMOR-NECROSIS-FACTOR-ALPHA PRODUCTION AND ENHANCES WEIGHT-GAIN IN PATIENTS WITH PULMONARY TUBERCULOSIS [J].

TRAMONTANA, JM ;

UTAIPAT, U ;

MOLLOY, A ;

AKARASEWI, P ;

BURROUGHS, M ;

MAKONKAWKEYOON, S ;

JOHNSON, B ;

KLAUSNER, JD ;

ROM, W ;

KAPLAN, G .

MOLECULAR MEDICINE, 1995, 1 (04) :384-397

← 1 →